[在异性干细胞移植后输入捐赠者淋巴细胞]
Christoph Schmid1, Hans-Jochem Kolb2
1Professur für Stammzell-Transplantation und Zelltherapieforschung, Universitätsklinikum Augsburg, Stenglinstr. 2, 86156, Augsburg, Deutschland. christoph.schmid@uk-augsburg.de.
Innere Medizin (Heidelberg, Germany)
|July 1, 2025
概括
供体淋巴细胞输液 (DLI) 是一种细胞免疫疗法,在干细胞移植后用于对抗血液癌症. 虽然它是有效的,但它带有诸如移植与宿主疾病等风险,需要仔细选择患者和剂量.
科学领域:
- 免疫治疗是一种免疫疗法.
- 血液学恶性瘤是什么
- 干细胞移植 干细胞移植
背景情况:
- 供体淋巴细胞输注 (DLI) 是最古老的细胞免疫疗法,在异构干细胞移植后使用了30多年.
- 它的有效性依赖于移植对恶性 (GvM) 反应,在这种反应中,捐赠者免疫细胞向剩余癌症.
- 疾病对GvM的敏感性有所不同,影响DLI的适应症和治疗组合.
研究的目的:
- 总结一下DLI的基本原则.
- 审查DLI在治疗血液性瘤中的临床应用和疗效.
- 根据注册表数据,提出关于DLI实施的当前建议.
主要方法:
- 审查历史数据和从狗模型中发现的结果.
- 对为血液性恶性瘤接受DLI的患者临床结果的分析.
- 综合大型注册表数据,制定实际建议.
主要成果:
- DLI主要用于预防和治疗异构移植后血液癌症复发.
- 移植与宿主疾病 (GvD) 是一个主要的并发症,受HLA匹配,DLI剂量和时间的影响.
- 已建立的建议有助于在各种临床场景中切实实施DLI.
结论:
- 在移植后的血液性恶性瘤中,DLI仍然是一个有价值的免疫疗法.
- 仔细考虑GvM敏感性和GvHD风险对于最佳的DLI应用至关重要.
- 基于证据的建议有助于在临床实践中安全有效地使用DLI.
更多相关视频
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.5K
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.0K
相关概念视频
Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Cell-mediated Immune Responses
73.7K
Overview
73.7K
